A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes

Ankita Barua Global Primary Intelligence, IQVIA, Rotkreuz, Switzerland

https://orcid.org/0000-0003-1546-015X View further author information

Sadaf Amirb Primary Intelligence, IQVIA, Gurgaon, India

https://orcid.org/0000-0001-6289-1505 View further author information

Magnus Ekelundc M&S, Insulin and Digital Health, Søborg, Denmark

https://orcid.org/0000-0003-0527-6412 View further author information

Roberta Montagnolid Region Europe HEOR, Novo Nordisk, Rome, Italy

https://orcid.org/0000-0002-0933-8919 View further author information

João Diogo Da Rocha Fernandese Real World Evidence, Global Patient Access, Søborg, DenmarkCorrespondence[email protected]

https://orcid.org/0000-0002-0036-0749 View further author information

Citations (7)

Keep up to date with the latest research on this topic with citation updates for this article.

Articles from other publishers (7)

Francesco Giorgino, Tadej Battelino, Richard M. Bergenstal, Thomas Forst, Jennifer B. Green, Chantal Mathieu, Helena W. Rodbard, Oliver Schnell & Emma G. Wilmot. (2023) The Role of Ultra-Rapid-Acting Insulin Analogs in Diabetes: An Expert Consensus. Journal of Diabetes Science and Technology.
Crossref

Arti Yadav, Rakesh Kumar, Devi Dayal, Jaivinder Yadav, Smita Pattanaik & Amol Patil. (2023) Effect of Postmeal Fast-Acting Insulin Aspart Injection on the Frequency of Hypoglycemia among Pre-School Children with Type 1 Diabetes: An Open-Label, Cross-Over, Randomized Control Trial. Indian Journal of Pediatrics.
Crossref

Christophe E. M. De Block, Jolijn Van Cauwenberghe, Niels Bochanen & Eveline Dirinck. (2022) Rapid‐acting insulin analogues: Theory and best clinical practice in type 1 and type 2 diabetes . Diabetes, Obesity and Metabolism.
Crossref

Wendy Lane, Elena Favaro, Esteban Jódar, Pranav Kelkar, Alejandra Oviedo, Ramsathish Sivarathinasami, Peter A. Senior, Giorgio Sesti & Edward Franek. (2022) Effective Overall Glycaemic Control with Fast-Acting Insulin Aspart Across Patients with Different Baseline Characteristics: A Post Hoc Analysis of the Onset 9 Trial. Diabetes Therapy 13:4, pages 761-774.
Crossref

Lisa Billion, Sara Charleer, Laurens VerbraekenJunior RegJunior Reg, Mira SterckxJunior RegJunior Reg, Kato VangelabbeekJunior RegJunior Reg, Nathalie Block, Charlien Janssen, Kristof DesselNutritioniNutritioni, Eveline Dirinck, Frida Peiffer, Nancy Bolsens, Chantal Mathieu, Pieter Gillard & Christophe Block. (2021) Glucose control using fast‐acting insulin aspart in a real‐world setting: A 1 ‐year, two‐centre study in people with type 1 diabetes using continuous glucose monitoring . Diabetes, Obesity and Metabolism 23:12, pages 2716-2727.
Crossref

Wendy Lane, Mads Faurby, Lise Lotte N. Husemoen, Dmitriy L. Markovich, Naveen Rathor & Christophe De Block. (2021) Glycaemic Control in People with Diabetes Starting Treatment with Fast-Acting Insulin Aspart: a US Database Study. Diabetes Therapy 12:12, pages 3067-3077.
Crossref

Sohaib Mehmood, Imran Ahmad, Hadeeqa Arif, Umm Ammara & Abdul Majeed. (2020) Artificial Pancreas Control Strategies Used for Type 1 Diabetes Control and Treatment: A Comprehensive Analysis. Applied System Innovation 3:3, pages 31.
Crossref

A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes

Articles from other publishers (7)

Information for

Open access

Opportunities

Help and information

Your download is now in progress and you may close this window

Login or register to access this feature

A survey of physician experience and treatment satisfaction using fast-acting insulin aspart in people with type 1 or type 2 diabetes

Citations (7)

Articles from other publishers (7)

Related research

To cite this article:

Download citation

Information for

Open access

Opportunities

Help and information

Keep up to date